![Jean Nichols](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean Nichols
Plus aucun poste en cours
Historique de carrière de Jean Nichols
Anciens postes connus de Jean Nichols
Sociétés | Poste | Début | Fin |
---|---|---|---|
Gloucester Pharmaceuticals, Inc.
![]() Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | President | - | 26/04/2011 |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Stonegate Partners LLC
![]() Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm. | Directeur des opérations | - | - |
Seragen, Inc.
![]() Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | President | - | - |
Formation de Jean Nichols
The University of North Carolina at Charlotte | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
President | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Gloucester Pharmaceuticals, Inc.
![]() Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gloucester Pharmaceuticals, Inc. develops products for the treatment of cancer patients. Its programs include cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL), and multiple myeloma. The company was founded in May 2003 and is headquartered in Cambridge, MA | Health Technology |
Seragen, Inc.
![]() Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
Stonegate Partners LLC
![]() Stonegate Partners LLC Financial ConglomeratesFinance Stonegate Partners LLC is a private equity firm. | Finance |
- Bourse
- Insiders
- Jean Nichols
- Expérience